The Keap1-Nrf2-antioxidant response element pathway: A review of its regulation by melatonin and the proteasome

Molecular and Cellular Endocrinology

Volumn 401, Issue , 2015, Pages 213-220

  Vriend, Jerry ^a   Reiter, Russel J ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bax; Bcl 2; Keap1; Melatonin; NF B; Proteasome

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MELATONIN; PROTEASOME; PROTEASOME INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; HUMAN; MITOCHONDRIAL DYNAMICS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN INTERACTION; REDOX STRESS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL NUCLEUS; DRUG EFFECTS; METABOLISM; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CELL NUCLEUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELATONIN; NF-E2-RELATED FACTOR 2; PROTEASOME INHIBITORS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84922335135     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.12.013     Document Type: Review

References (133)

1. Abd El Mohsen M.M., Iravani M.M., Spencer J.P.E., Rose S., Fahim A.T., Motawi T.M.K., et al. Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants. Biochem. Biophys. Res. Commun 2005, 336:386-391.
2. Austin S., St-Pierre J. PGC1α and mitochondrial metabolism - emerging concepts and relevance in ageing and neurodegenerative disorders. J. Cell Sci 2012, 125:4963-4971.
3. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int 1995, 26:497-502.
4. Baydas G., Ercel E., Canatan H., Donder E., Akyol A. Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem. Funct 2001, 19:37-41.
5. Bejarano I., Espino J., Barriga C., Reiter R.J., Pariente J., Rodriguez A.B. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apototic effects. Basic Clin. Pharmacol. Toxicol 2011, 108:14-20.
6. Bejarano I., Monllor F., Marchena A.M., Ortiz A., Lozano G., Jimenez M.I., et al. Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa. J. Pineal Res 2014, 57:333-339.
7. Bekyarova G., Apostolova M., Kotzev I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor kappa B activation. Int. J. Immunopathol. Pharmacol 2012, 25:591-596.
8. Bekyarova G., Tzaneva M., Hristova M. Melatonin modulates the expression of Bcl-2 family proteins in liver after thermal injury in rats. Adv. Biosci. Biotechnol 2013, 4:41-47.
9. Bizzarri M., Proietti S., Cucina A., Reiter R.J. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin. Ther. Targets 2013, 17:1483-1496.
10. Blask D.E., Dauchy R.T., Dauchy E.M., Mao L., Hill S.M., Greene M.W., et al. Light exposure at night disrupts host/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth prevention. PLoS ONE 2014, 9:e85311.
11. Bonnefont-Rousselot D., Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010, 278:55-67.
12. Bruck R., Aeed H., Avni Y., Shirin H., Matas Z., Shahmurov M., et al. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J. Hepatol 2004, 40:86-93.
13. Buyukavci M., Ozdemir O., Buck S., Stout M., Ravindranath Y., Savaşan S. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam. Clin. Pharmacol 2006, 20:73-79.
14. + depletion enhances bortezomib-induced anti-myeloma activity. Blood 2013, 122:1243-1255.
15. Canonico B., Luchetti F., Ambrogini P., Arcangeletti M., Betti M., Cesarini E., et al. Pharmacological does of melatonin induce alterations in mitochondrial mass and potential, bcl-2 levels and K+ currents in UVB-exposed U937 cells. Cell Biol. Int 2013, 37:213-226.
16. Chapple S.J., Siow R.C., Mann G.E. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int. J. Biochem. Cell Biol 2012, 44:1315-1320.
17. Charan R.A., Johnson B.N., Zaganelli S., Nardozzi J.D., LaVoie M.J. Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin. Cell Death Dis 2014, (in press).
18. Chen Z.J. Ubiquitin signaling in the NF-kappaB pathway. Nat. Cell Biol 2005, 7:758-765.
19. Cherry A.D., Suliman H.B., Bartz R.R., Piatadosi C.A. Peroxisome proliferator-activated receptor γ co-activator 1-α as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis. J. Biol. Chem 2014, 289:41-52.
20. Choi E.Y., Jin J.Y., Lee J.Y., Choi J.I., Choi I.S., Kim S.J. Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity. J. Pineal Res 2011, 50:197-206.
21. Chowdhry S., Zhang Y., McMahon M., Sutherland C., Cuadrado A., Hayes J.D. Nrf2 is controlled by two distinct β-TrCP recognition sites in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2013, 32:3765-3781.
22. Chuang J.I., Natarajan M., Meltz M.L., Reiter R.J. Effects of melatonin on NF-κB DNA-binding activity in rat spleen. Cell Biol. Int 1996, 20:687-692.
23. Coppo R. Proteasome inhibitors in progressive renal diseases. Nephrol. Dial. Transplant 2014, (Suppl. 1):i25-i30.
24. Cuzzocrea S., Tan D.X., Costantino G., Mazzon E., Caputi A.P., Reiter R.J. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J. 1999, 13:1930-1938.
25. Demasi M., Silva G.M., Netto L.E. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch. Biochem. Biophys 2001, 389:254-263.
26. Demasi M., Netto L.E., Silva G.M., Hand A., de Oliveira C.L., Bicev R.N., et al. Redox regulation of the proteasome via S-glutathionylation. Redox Biol 2013, 2:44-51.
27. Deng Y., Zhu J., Mi C., Xu B., Jiao C., Li Y., et al. Melatonin antagonizes Mn-induced oxidative injury through the activation of Keap1-Nrf2-ARE signaling pathway in the striatum of mice. Neurotox. Res 2014, (in press).
28. Dias V., Junn E., Mouradian M.M. The role of oxidative stress in Parkinson's disease. J. Parkinsons Dis 2013, 3:461-491.
29. Ding K., Wang H., Xu J., Li T., Zhang L., Ding Y., et al. Melatonin stimulated antioxidant enzymes and reduced oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radic. Biol. Med 2014, 73:1-11.
30. Du Z.X., Yan Y., Zhang H.Y., Liu B.Q., Gao Y.Y., Niu X.F., et al. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells. J. Clin. Endocrinol. Metab 2011, 96:E763-E771.
31. Farhoud M.H., Nijtmans L.G., Wanders R.J.A., Wessels H.J.C.T., Lasonder E., Janssen A.J., et al. Impaired ubiquitin-proteasome-mediated PGC-1a protein turnover and induced mitochondrial biogenesis secondary to complex-I deficiency. Proteomics 2012, 12:1349-1362.
32. Fischer T.W., Kleszczynski K., Hardkop L.H., Kruse N., Zillikins D. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy- 2'-deoxyguanosine) in ex vivo human skin. J. Pineal Res 2013, 53:303-312.
33. Fuchs O. Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma. Cardiovasc. Hematol. Disord. Drug Targets 2013, 13:16-34.
34. Furukawa M., Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol 2005, 162-171.
35. Galano A. On the direct scavenging ability of melatonin towards hydroxyl and a series of peroxyl radicals. Phys. Chem. Chem. Phys 2011, 115:4538-4546.
36. Galano A., Tan D.X., Reiter R.J. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J. Pineal Res 2011, 51:1-16.
37. Garcia J.J., Lopez-Pingarron L., Almedia-Souza P., Tres A., Escudero P., Garcia-Gil F.A., et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J. Pineal Res 2014, 56:225-237.
38. Genin E., Rebod-Ravaux N., Vidal J. Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry. Curr. Top. Med. Chem 2010, 10:232-256.
39. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NF-kappaB activation. FASEB J. 1998, 12:685-693.
40. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol 2006, 72:1493-1505.
41. Graff J.W., Ettayebi K., Hardy M.E. Rotovirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of Beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog 2009, 5:e1000280.
42. Greco T., Fiskum G. Neuroprotection through stimulation of mitochondrial antioxidant protein expression. J. Alzheimers Dis 2010, (Suppl. 2):S427-S437.
43. Grimm L.M., Goldberg A.L., Poirier G.G., Schwartz L.M., Osborne B.A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 1996, 15:3835-3844.
44. Guo P., Pi H., Xu S., Zhang L., Li Y., Li M., et al. Melatonin improves mitochondrial function by promoting MT1/SIRT1/PGC-2 alpha-dependent mitochondrial biogenesis in cadmium-induced hepatotoxicity in vitro. Toxicol. Sci 2014, 142:182-195.
45. Gutierrez-Cuesta J., Tajes M., Jimenez A., Coto-Montes A., Camins A., Pallas M. Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model. J. Pineal Res 2008, 45:497-505.
46. Hardeland R., Cardinali D.P., Srinivasan V., Spence D.W., Brown G.M., Pandi-Perumal S.R. Melatonin - a pleiotropic, orchestrating regulator molecule. Prog. Neurobiol 2011, 93:350-384.
47. Hill S.M., Cheng C., Yuan L., Mao L., Jockers R., Dauchy B., et al. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth. Curr. Aging Sci 2013, 6:125-133.
48. Hong Y., Won J., Lee Y., Lee S., Park K., Chang K.T., et al. Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J. Pineal Res 2014, 56:264-274.
49. Hong Y.S., Hong S.W., Kim S.M., Jin D.H., Shin J.S., Yoon D.H., et al. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1. Int. J. Oncol 2012, 41:76-82.
50. Hota K.B., Hota S.K., Chaurasia O.O.P., Singh S.B. Aceyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERL1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 2012, 22:723-736.
51. Huang S.H., Cao X.J., Wei W. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. J. Pineal Res 2008, 45:93-100.
52. Ito T., Deng X., Carr B., May W.S. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem 1997, 272:11671-11673.
53. Jardim-Perassi B.V., Arbab A.S., Ferreira L.C., Borin T.F., Varma N.R., Iskander A.S., et al. Effect of melatonin on tumor growth and angiogenesis in zenograft model of breast cancer. PLoS ONE 2014, 9:e85311.
54. Johnson B.N., Berger A.K., Cortese G.P., Lavoie M.J. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:6283-6288.
55. Joshi G., Johnson J.A. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat. CNS Drug Discov 2012, 7:218-229.
56. Juknat A.A., Mendez Mdel V., Quaglino A., Fameli C.I., Mena M., Kotler M.L. Melatonin prevents hydrogen peroxide-induced Bax expression in cultured rat astrocytes. J. Pineal Res 2005, 38:84-92.
57. Jun Z., Li Z., Fang W., Fengzhen Y., Puyuan W., Wenwen L., et al. Melatonin decreases levels of S100β and NFKβ, increases levels of synaptophysin in a rat model of Alzheimer's disease. Curr. Aging Sci 2013, 36:152-163.
58. Jung K.H., Hong S.W., Zheng H.M., Lee D.H., Hong S.S. Melatonin downregulates nuclear erythroid 2-related factor and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model. J. Pineal Res 2009, 47:173-183.
59. Jung K.H., Hong S.W., Zheng H.M., Lee H.S., Lee H., Lee D.H., et al. Melatonin ameliorates cerulean-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J. Pineal Res 2010, 48:239-250.
60. Kanarek N., Ben-Neriah Y. Regulation of NF-κB by ubiquitination and degradation of the IkBs. Immunol. Rev 2012, 246:77-94.
61. Kilic U., Kilic E., Tuzcu Z., Tuzcu M., Ozercan I., Yilmaz O., et al. Melatonin suppresses ciplatin-induced nephrotoxicity via activation of Nrf-2/Ho-1 pathway. Nutr. Metab 2013, 10:7. 10.1186/1743-7075-10-7.
62. Kwak M.K., Wakabayashi N., Greenlaw J.L., Yamamoto M., Kensler T.W. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol 2003, 23:8786-8794.
63. Lanoix D., Lacasse A.A., Reiter R.J., Vaillancourt C. Melatonin: the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis. Mol. Cell. Endocrinol 2013, 381:35-45.
64. Lavoie M.J., Cortese G.P., Ostaszewski B.L., Schlossmacher M.G. The effects of oxidative stress on parkin and other E3 ligases. J. Neurochem 2007, 103:2354-2368.
65. Lee D.F., Kuo H.P., Liu M., Chou C.K., Xia W., Du Y., et al. Keap1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol. Cell 2009, 36:131-140.
66. Leja-Szpak A., Jaworek J., Pierzchalski P., Reiter R.J. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J. Pineal Res 2010, 49:248-255.
67. Li H., Wang Y., Feng D., Liu Y., Xu M., Gao A., et al. Alterations in the time course of the Nox family in the brain in a rat experimental cerebral ischemia and reperfusion model; effects of melatonin. J. Pineal Res 2014, 57:110-119.
68. Li J.H., Yu J.P., Yu H.G., Xu X.M., Yu L.L., Liu J., et al. Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm 2005, 31:185-193.
69. Ling Y.H., Liebes L., Zou Y., Perez-Solar R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J. Biol. Chem 2003, 278:33714-33723.
70. Macari E.R., Lowrey C.H. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway. Blood 2011, 117:5987-5997.
71. Marshansky V., Wang X., Bertrand R., Luo H., Duguid W., Chinnadurai G., et al. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J. Immunol 2001, 166:3130-3142.
72. Mercer J., Snijder B., Sacher R., Burkard C., Bleck C.K., Stahlberg H., et al. RNAi screening reveals proteasome- and cullin3-dependent stages in vaccinia virus infection. Cell Rep 2012, 2:1036-1047.
73. Min K.J., Jang J.H., Kwon T.K. Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of AKT-induced NF-κB and STAT/GAS activity. J. Pineal Res 2012, 52:296-304.
74. Mohseni M., Mihandoost E., Shirazi A., Sepehrizadeh Z., Bazzaz J.T., Ghazi-khansari M. Melatonin may play a role in modulation of bax and bcl-2 expression levels to protect rat peripheral blood lymphocytes from gamma irradiation-induced apoptosis. Mutat. Res 2012, 738-739:19-27.
75. Mollaoglu H., Topal T., Ozler M., Uysal B., Reiter R.J., Korkmaz A., et al. Antioxidant effects of melatonin in rats during chronic exposure to hyperbaric oxygen. J. Pineal Res 2007, 42:50-54.
76. Natarajan M., Sadeghi K., Reiter R.J., Meltz M.L. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem. Mol. Biol. Int 1995, 37:1063-1070.
77. Natoli G., Chiocca S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. Sci. Signal 2008, 1:pe1.
78. Negi G., Kumar A., Sharma S.S. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J. Pineal Res 2011, 50:124-131.
79. Nguyen T., Sherratt P.J., Huang H.C., Yang C.S., Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S proteasome. J. Biol. Chem 2003, 278:4536-4541.
80. Niture S.K., Jaiswal A.K. Nrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. Cell Death Differ 2011, 18:439-451.
81. Niture S.K., Jaiswal A.K. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phophoglycerate mutase 5 and controls cellular apoptosis. J. Biol. Chem 2011, 286:44542-44556.
82. Pablos M.I., Reiter R.J., Ortiz G.G., Guerrero J.M., Agapito M.T., Chuang J.I., et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int 1998, 32:69-75.
83. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
84. Park E.J., Woo S.M., Min K.J., Kwon T.K. Transcriptional and post-translational regulation of Bim controls apoptosis in melatonin-treated human renal cancer Caki cells. J. Pineal Res 2014, 56:97-106.
85. Perkins N. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol 2007, 8:49-62.
86. Piantadosi C.A., Carraway M.S., Babiker A., Suliman H.B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res 2008, 103:1232-1240.
87. Pullarkat V., Meng Z., Tahara S.M., Johnson C.S., Kalra V.K. Proteasome inhibition induces both antioxidant and hb f response in sickle cell disease via the nrf2 pathway. Hemoglobin 2014, 38:188-195.
88. Qin W., Lu W., Li H., Yuan X., Li B., Zhang Q., et al. Melatonin inhibits IL 1β-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-κB activation. J. Endocrinol 2012, 214:145-153.
89. Radogna F., Cristofanon S., Paternoster L., D'Alessio M., De Nicola M., Cerella C., et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J. Pineal Res 2008, 44:316-325.
90. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995, 9:526-533.
91. Reiter R.J. Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals. Eur. J. Endocrinol 1996, 134:412-420.
92. Reiter R.J., Tan D.X., Rosales-Corral S., Manchester L.C. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev. Med. Chem 2013, 13:373-384.
93. Reiter R.J., Tan D.X., Galano A. Melatonin reduces lipid peroxidation and membrane viscosity. Front. Physiol 2014, 5. article 377.
94. Sainz R.M., Mayo J.C., Rodriguez C., Tan D.X., Lopez-Burillo S., Reiter R.J. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell. Mol. Life Sci 2003, 60:1407-1426.
95. Sayyed H.G., Jaumdally R.J., Idriss N.K., El Sers D.A., Blann A. The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat. Dig. Dis. Sci 2013, 58:3156-3164.
96. Schwimmer H., Metzer A., Pilosof Y., Szyf M., Machnes Z.M., Fares F., et al. Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation. Chronobiol. Int 2014, 31:144-150.
97. Shamoto-Nagai M., Maruyama W., Kato Y., Osobe K., Tanaka M., Naoi M., et al. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J. Neurosci. Res 2003, 74:589-597.
98. Shang F., Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med 2011, 51:5-16.
99. Shi D., Xiao X., Wang J., Liu L., Chen W., Fu L., et al. Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL 1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling. J. Pineal Res 2012, 53:154-165.
100. Singh S., Vrishni S., Singh B.K., Rahman I., Kakkar P. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and inflammatory diseases. Free Radic. Res 2010, 44:1267-1288.
101. Sun Z., Zhang S., Chan J.Y., Zhang D.D. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol 2007, 27:6334-6349.
102. Surh Y.J., Kundu J.K., Na H.K. Nfr2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008, 74:1526-1539.
103. Taguchi K., Motohashi H., Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011, 16:123-140.
104. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1:57-60.
105. Tan D.X., Manchester L.C., Sainz R.M., Mayo J.C., Leon J., Hardeland R., et al. Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J. Pineal Res 2005, 39:185-194.
106. Tan X., Guo X., Liu H. Melatonin attenuates hippocampal neuron apoptosis and oxidative stress during chronic intermittent hypoxia via up-regulating B-cell lymphoma-2 and down-regulating C-cell lymphoma-2 associated X protein. Saudi Med. J. 2013, 34:701-708.
107. Taylor E.B., Rutter J. Mitochondrial quality control by the ubiquitin-proteasome system. Biochem. Soc. Trans 2011, 39:1509-1513.
108. Tian H., Zhang B., Di J., Jiang G., Chen F., Li H., et al. Keap1: one stone kills three birds Nrf2, IKKβ, and Bcl-2/Bcl-xL. Cancer Lett 2012, 325:26-34.
109. Tomas-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res 2005, 39:366-375.
110. Traenchner E.B., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 1994, 13:5433-5441.
111. Trausch-Azar J.S., Abed M., Orian A., Schwartz A.L. Isoform-specific SCFFbw7 ubiquitination mediates differential regulation of PGC-1α. J. Cell. Physiol 2014, (in press), [epub ahead of print].
112. Tripathi D.N., Jena G.B. Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide induced urinary bladder injury in rat. J. Pineal Res 2010, 48:324-331.
113. Tsvetkov P., Myers N., Eliav R., Adamovich Y., Hagai T., Adler J., et al. NADH binds and stabilizes the 26S proteasomes independent of ATP. J. Biol. Chem 2014, 289:11272-11281.
114. Villeneuve N.F., Lau A., Zhang D.D. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin-proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid. Redox Signal 2010, 13:1699-1712.
115. Vomhof-DeKrey E.E., Picklo M.J. The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J. Nutr. Biochem 2012, 1201-1206.
116. Vriend J., Reiter R.J. Melatonin as a proteasome inhibitor. Is there any clinical evidence?. Life Sci 2014, 115:8-14.
117. Wan L., Tan M., Yang J., Inzuka H., Dai X., Wu T., et al. APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. Dev. Cell 2014, 27:377-391.
118. Wang F.W., Wang Z., Zhang Y.M., Du Z.X., Zhang X.L., Liu Q., et al. Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro. J. Cell. Biochem 2013, 114:2346-2355.
119. Wang Q., Burles K., Couturier B., Randall C.M., Shisler J., Barry M. Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NF-κB signaling. J. Virol 2014, 88:4853-4865.
120. Wang X., Luo H., Chen H., Duguid W., Wu J. Role of proteasomes in T cell activation and proliferation. J. Immunol 1998, 160:788-801.
121. Wang Z., Ma C., Meng C.J., Zhu G.Q., Sun X.B., Huo L., et al. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. J. Pineal Res 2012, 53:129-137.
122. Wu Z., Shi Y. Where ubiquitin meets NF-kB: a trove for anti-cancer drug development. Curr. Pharm. Des 2013, 19:3263-3675.
123. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
124. Yang Y., Jiang S., Yan J., Li Y., Xin Z., Lin Y., et al. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev 2014, (in press).
125. Yang Y., Sun Y., Yi W., Li Y., Fan C., Xin Z., et al. A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J. Pineal Res 2014, 57:357-366.
126. Yerlikaya A. Expression of heme oxygenase-1 in response to proteasomal inhibition. Protein Pept. Lett 2012, 19:1330-1333.
127. Yoo Y.M., Yim S.V., Kim S.S., Jang H.Y., Lea H.Z., Hwang G.C., et al. Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-β immortalized pineal cells. J. Pineal Res 2002, 33:146-150.
128. Yu C., Rahmani M., Dent P., Grant S. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. Exp. Cell Res 2004, 295:555-566.
129. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev 2006, 38:769-789.
130. Zhang H.M., Zhang Y. Melatonin a well-documented antioxidant with conditional pro-oxidant actions. J. Pineal Res 2014, 57:131-246.
131. Zhang M., An C., Gao Y., Leak R.K., Chen J., Zhang F. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog. Neurobiol 2013, 100:30-47.
132. Zhou J., Yang F., Wang J.G., Wen P., Luo H., Li W., et al. Dietary melatonin attenuates age-related changes in morphology and in levels of key proteins in globus pallidus of mouse brain. Brain Res 2014, 1546:1-8.
133. Zhou W., Wei W., Sun Y. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Res 2013, 23:599-619.